CMS Expands Patient-Centered Innovation with Substance Access BEI

The Centers for Medicare & Medicaid Services (CMS) has introduced the Substance Access Beneficiary Engagement Incentive (BEI)

The Centers for Medicare & Medicaid Services (CMS) has introduced the Substance Access Beneficiary Engagement Incentive (BEI), a new initiative aimed at advancing patient-centered care through innovative treatment options.

A key feature of this model is the inclusion of hemp-derived products. Participating organizations, with CMS approval, may provide eligible beneficiaries up to $500 per year in hemp-derived products—subject to clinical determination, model requirements, and safeguards.

To qualify, products must comply with the 2018 Agriculture Improvement Act, containing no more than 0.3% delta-9 THC. The model excludes inhalable products, items with more than 3 mg of THC per serving, and any cannabinoids not naturally produced by the cannabis plant. Importantly, the initiative does not override the Controlled Substances Act or authorize Schedule I substances.

All eligible products must meet strict federal, state, and local requirements, including third-party testing for potency and contaminants, ensuring safety and quality.

This milestone reflects CMS’s commitment to expanding safe, compliant, and patient-focused care options while maintaining strong regulatory oversight.

For more details, read the full CMS announcement:https://www.cms.gov/newsroom/press-releases/cms-marks-milestone-expanding-patient-centered-innovation-substance-access-beneficiary-engagement

---

Ag Hemp Solutions Is Here to Help!

Our services include consulting, lobbying, legislation and policy drafting, legislative strategy, policy monitoring, and tailored representation to help you navigate and influence federal and state policy. Secure your seat at the table and schedule a call with our team today, here.